ORGANIC
LETTERS
2010
Vol. 12, No. 17
3848-3851
An Efficient Approach to Functionalized
Benzo[a]xanthones through Reactions of
2-Methyl-3-(1-alkynyl)chromones with
Electron-Deficient Chromone-Fused
Dienes
Jian Gong, Fuchun Xie, Hong Chen, and Youhong Hu*
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica,
Chinese Academy of Science, 555 Zu Chong Zhi Road, Shanghai 201203, China
Received July 4, 2010
ABSTRACT
An efficient tandem process was developed to synthesize diversified benzo[a]xanthones from 2-methyl-3-(1-alkynyl)chromones with electron-
deficient chromone-fused dienes. This unusual reaction, involving multiple steps and not requiring the use of transition metal catalysts or an
inert atmosphere, results in the formation of three new C-C bonds and one C-O bond.
The xanthone framework is ubiquitous in a wide variety of
naturally occurring and synthetic compounds that exhibit
important biological activity.1 Consequently, interest in the
development of efficient methods for the synthesis of
xanthones, bearing multiple and diverse substitution patterns,
has continued.2 Only a few synthetic routes for the prepara-
tion of benzo[a]xanthones have been described. One method,
involving visible light induced photooxidative cyclization of
(E)-2-styrylchromones,3 requires long time periods and takes
place in only modest yields. Other approaches employ harsh
conditions or multistep sequences to obtain this target in low
yields.4 Below, we describe the results of an investigation
that has led to the development of a facile and efficient
method for the synthesis of functionalized benzo[a]xanthones
that utilizes mild reaction conditions.
Tandem reactions, which employ easily prepared inter-
mediates containing multiple reactive sites, serve as attractive
methods to generate complex molecular architectures, espe-
cially those present in natural product skeletons.5 Our earlier
work in this area focused on the use of functionalized 3-(1-
alkynyl)chromones to generate diversified natural product-
(1) (a) Sousa, M. E.; Pinto, M. M. Curr. Med Chem. 2005, 12, 2447,
and references cited therein. (b) Palmer, B. D.; Henare, K.; Woon, S. T.;
Sutherland, R.; Reddy, C.; Wang, L. C.; Kieda, C.; Ching, L. M. J. Med.
Chem. 2007, 50, 3757.
(2) For recent studies, see: (a) Santos, C. M. M.; Silva, A. M. S.;
Cavaleiro, J. A. S. Eur. J. Org.Chem. 2009, 2642. (b) Xu, W. Z.; Huang,
Z. T.; Zheng, Q. Y. J. Org. Chem. 2008, 73, 5606. (c) Dang, A. T.; Miller,
D. O.; Dawe, L. N.; Bodwell, G. J. Org. Lett. 2008, 10, 233. (d) Swamy,
N. K.; Tatini, L. K.; Babu, J. M.; Annamalai, P.; Pal, M. Chem. Commun.
2007, 1035. (e) Zhao, J.; Yue, D.; Campo, M. A.; Larock, R. C. J. Am.
Chem. Soc. 2007, 129, 5288. (f) Zhao, J.; Larock, R. C. J. Org. Chem.
2007, 72, 583. (g) Mondal, M.; Puranik, V. G.; Argade, N. P. J. Org. Chem.
2006, 71, 4992. (h) Zhao, J.; Larock, R. C. Org. Lett. 2005, 7, 4273. (i)
Hauser, F. M.; Dorsch, W. A. Org. Lett. 2003, 5, 3753.
(3) Silva, A. M. S.; Pinto, D. C. G. A.; Tavares, H. R.; Cavaleiro, J. A. S.;
Jimeno, M. L.; Elguero, J. Eur. J. Org. Chem. 1998, 2031.
(4) (a) Brito, C. M.; Pinto, D. C. G. A.; Silva, A. M. S.; Silva, A. M. G.;
Tome, A. C.; Cavaleiro, J. A. S. Eur. J. Org. Chem. 2006, 2558. (b) Knight,
D. W.; Little, P. B. J. Chem. Soc., Perkin. Trans. 1 2001, 1771. (c) Gabbutt,
C. D.; Hepworth, J. D.; Heron, B. M.; Thomas, J. L. Tetrahedron Lett.
1998, 39, 881. (d) Horne, S. J. Org. Chem. 1990, 55, 4520. (e) Yokoe, I.;
Higuchi, K.; Shirataki, Y.; Komatsu, M. Chem. Pharm. Bull. 1981, 29, 2670.
10.1021/ol101496w 2010 American Chemical Society
Published on Web 08/12/2010